{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T22:21:43Z","timestamp":1775600503309,"version":"3.50.1"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T00:00:00Z","timestamp":1689638400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadinternational.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD International"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jdin.2023.07.006","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T22:33:53Z","timestamp":1689892433000},"page":"48-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["The 2022 CDC opioid prescription guideline update: Relevant recommendations and future considerations"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6311-5193","authenticated-orcid":false,"given":"Ameya","family":"Gangal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Stoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Travis","family":"Blalock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdin.2023.07.006_bib1","series-title":"CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United\u00a0States, 2022","author":"Dowell","year":"2022"},{"key":"10.1016\/j.jdin.2023.07.006_bib2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3109\/09546634.2014.951304","article-title":"Use of opioid analgesics in skin disorders: results from a nationally representative US sample","volume":"26","author":"Gupta","year":"2015","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jdin.2023.07.006_bib3","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1097\/DSS.0000000000003567","article-title":"Bupivacaine to reduce pain and narcotic use after Mohs micrographic surgery","volume":"48","author":"Voss","year":"2022","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jdin.2023.07.006_bib4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jamadermatol.2017.5835","article-title":"Opioid prescribing patterns and complications in the dermatology Medicare population","volume":"154","author":"Cao","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jdin.2023.07.006_bib5","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jaad.2019.09.080","article-title":"An expert panel consensus on opioid-prescribing guidelines for dermatologic procedures","volume":"82","author":"McLawhorn","year":"2020","journal-title":"J Am Acad Dermatol"}],"container-title":["JAAD International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266632872300113X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266632872300113X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T21:00:44Z","timestamp":1762981244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266632872300113X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":5,"alternative-id":["S266632872300113X"],"URL":"https:\/\/doi.org\/10.1016\/j.jdin.2023.07.006","relation":{},"ISSN":["2666-3287"],"issn-type":[{"value":"2666-3287","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The 2022 CDC opioid prescription guideline update: Relevant recommendations and future considerations","name":"articletitle","label":"Article Title"},{"value":"JAAD International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdin.2023.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}